Pre-Treatment and Post-Treatment Anxiety, Depression, Sleep and Sexual Function Levels in Patients with Breast Cancer

In order to determine theanxiety, depression, sleep and sexual function levels, Sociodemographic and Clinical Data Form, Hospital Anxiety Depression Scale (HADS), Pittsburgh Sleep Quality Scale (PSQI) and Arizona Sexual Experiences Scale (ASEX) scores are utilized at pre-treatment and post-treatment phases forpatients with breast cancer and our control group.Results: According to scale scores applied to patients and control group, it has been determined that patients with breast cancer HADS sexualand sleep disorders, that their HADS and PSQI scores were higher and that ASEX scores decreased significantly (p

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Objective: In the phase of diagnosis and treatment of breast cancer cases, patients can usually experience sexual dysfunctions, sleep disorders andpsychiatric disorders such as anxiety and depression.

📊

Key Findings & Data:The main objective of our research is to study of the pre-treatment and post-treatment anxiety,depression, sleep and sexual function levels in the patients with breast cancer.Materials and Methods: Fifty-six patients with breast cancer and 52 healthy women have participated in our study.

💡

Conclusion & Impact:In order to determine theanxiety, depression, sleep and sexual function levels, Sociodemographic and Clinical Data Form, Hospital Anxiety Depression Scale (HADS), Pittsburgh Sleep Quality Scale (PSQI) and Arizona Sexual Experiences Scale (ASEX) scores are utilized at pre-treatment and post-treatment phases forpatients with breast cancer and our control group.Results: According to scale scores applied to patients and control group, it has been determined that patients with breast cancer HADS sexualand sleep disorders, that their HADS and PSQI scores were higher and that ASEX scores decreased significantly (p

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Objective: In the phase of diagnosis and treatment of breast cancer cases, patients can usually experience sexual dysfunctions, sleep disorders andpsychiatric disorders such as anxiety and depression. The main objective of our research is to study of the pre-treatment and post-treatment anxiety,depression, sleep and sexual function levels in the patients with breast cancer.Materials and Methods: Fifty-six patients with breast cancer and 52 healthy women have participated in our study. In order to determine theanxiety, depression, sleep and sexual function levels, Sociodemographic and Clinical Data Form, Hospital Anxiety Depression Scale (HADS), Pittsburgh Sleep Quality Scale (PSQI) and Arizona Sexual Experiences Scale (ASEX) scores are utilized at pre-treatment and post-treatment phases forpatients with breast cancer and our control group.Results: According to scale scores applied to patients and control group, it has been determined that patients with breast cancer HADS sexualand sleep disorders, that their HADS and PSQI scores were higher and that ASEX scores decreased significantly (p

🔖

Cite This Article

ERDOĞAN, Z., ÖZMEN, V., DUYMAZ, T., İLGÜN, A. S., ORDU, Ç., ALÇO, G., ÖZTÜRK, A., ELBÜKEN, F., AKTEPE, F., İZCİ, F., ÖZDEM, G., AĞAÇAYAK, F., ATEŞAL, K. C., DOĞAN, Ö. İ. (2022). Pre-Treatment and Post-Treatment Anxiety, Depression, Sleep and Sexual Function Levels in Patients with Breast Cancer. European Journal of Breast Health, Cilt: 16 - Sayı: 3, 219–225. https://ajindex.com/articles/510763

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (5)

Christensen H, Marck D. The efficacy of mindfulness based stress reduction (MBSR) for decreasing anxiety and depression among breast cancer survivors. Sch Physician Assist Stud 2017; 16: 613
Lueboonthavatchai P. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients. J Med Assoc Thai 2007; 90: 2164- 2174. (PMID: 18041438
Rogers LQ, Courneya KS, Anton PM, Verhulst S, Vicari SK, Robbs RS, McAuley E. Effects of a multicomponent physical activity behavior change intervention on fatigue, anxiety, and depressive symptomatology in breast cancer survivors: randomized trial. Psychooncology 2017; 26: 1901-1906. (PMID: 27530961) [Crossref] 4. Maass SWMC, Roorda C, Berendsen AJ, Verhaak PF, de Bock GH. The prevalence of long-term symptoms of depression and anxiety after breast cancer treatment: A systematic review. Maturitas 2015; 82: 100-108. (PMID: 25998574) [Crossref] 5. Vahdaninia M, Omidvari S, Montazeri A. What do predict anxiety and depression in breast cancer patients? A follow-up study. Soc Psychiatry Psychiatr Epidemiol 2010; 45: 355-361. (PMID: 19458878) [Crossref] 6. Reich M, Lesur A, Perdrizet-Chevallier C. Depression, quality of life and breast cancer: a review of the literature. Breast Cancer Res Treat 2008; 110: 9-17. (PMID: 17674188) [Crossref] 7. Savard J, Ivers H, Villa J, Caplette-Gingras A, Morin CM. Natural course of insomnia comorbid with cancer: an 18-month longitudinal study. J Clin Oncol 2011; 29: 3580-3586. (PMID: 21825267) [Crossref] 8. Chen PJ, Huang CL, Weng SF, Wu MP, Ho CH, Wang JJ, Tsai WC, Hsu YW. Relapse insomnia increases greater risk of anxiety and depression: evidence from a population-based 4-year cohort study. Sleep Med 2017; 38: 122-129. (PMID: 29031746) [Crossref] 9. Can G. Kanserde cinsel sağlık. Androloji Bülteni Hemşire Çalışma Grubu 2004; 19: 355-356
Eti F. Mastektomili hastalara ameliyat öncesi ve sonrası uygulanan hemşirelik bakımının beden imajını algılama ve fiziksel iyileşme üzerine etkisi. İstanbul Üniversitesi Sağlık Bilimleri Enstitüsü Cerrahi Hastalıkları Hemşireliği Anabilim Dalı, Doktora Tezi, İstanbul. 1992 11. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Clinical Version (SCID-I/CV). American Psychiatric Press, Washington D.C 1997
Çorapcıoğlu A, Aydemir Ö, Yıldız M, Esen A, Köroğlu E. DSM-IV Eksen I Bozuklukları (SCID-I)için yapılandırılmış klinik görüşme, klinik versiyon. Hekimler Yayın Birliği Matbaası, Ankara, 19